CLINICAL ROLE -
Blinatumomab Nearly Doubles Overall Survival in B-Cell Precursor Acute Lymphoblastic Leukemia
Drug may offer an effective alternative to chemotherapy for patients with leukemia.
Read More
Omnipod System Reaches Milestone, Continues to Improve Diabetes Management
Senior Executives with Insulet Corporation recently announced their milestone of achieving 100,000 active users worldwide of the Omnipod® Insulin Management System.
Pertuzumab-Based Regimen Improves Survival in HER2-Positive Early Breast Cancer
Combination treatment helped increase invasive disease-free survival in patients with an aggressive type of early breast cancer.
Maryland Declares State of Emergency Over Opioid Epidemic
Maryland allocates an additional $50 million over 5 years to combat opioid misuse.
Coal Mine Discovery May Improve Cancer Care
Newly-discovered microbial products shown to impact a protein used in certain cancer treatments.
Cooling Caps Reduce Chemotherapy-Related Hair Loss
Although scalp-cooling caps reduce hair loss, insurers do not cover the treatment.
Updated Clinical Guideline of Palliative Radiation Therapy for Painful Bone Metastases
Analysis confirms the safety and efficacy of palliative radiation therapy for painful bone metastases.
Evidence-Based Medicine Optimal for Diabetes Treatment
Some patients may not benefit from strict blood sugar control.
Antibiotics May Increase Bacterial Growth
Doxycycline was seen to mutate E. coli in a way that leads to producing colonies 3 times larger.
Trending News Today: Atopic Dermatitis Drug Shows Promise
Top news of the day from across the health care landscape.
Trending News Today: Motives of Some Patient Advocacy Groups in Question
Top news of the day from across the healthcare landscape.
Ketogenic Diet for Diabetes: Recent Research Shows Good Results
When patients are diagnosed with type 2 diabetes, clinicians stress lifestyle modifications—and especially diet—as the first and best intervention.
Pharmaceutical Inspections in Europe, US to Get New Framework
Since May 2014, the FDA and the EU have been collaborating to evaluate the way they each inspect drug manufacturers and assessing the risk and benefits of mutual recognition of drug inspections.
High-involvement Cognitive Messaging: Increasing Tdap Uptake
The number of outbreaks of pertussis across the country has been growing.
FDA Approves Treatment for House Dust Mite Allergy
Odactra is a once-daily tablet that exposes patients to house dust mite allergens, gradually training the immune system to reduce the frequency and severity of nasal and eye allergy symptoms.
Complications Vary Greatly Among Youth with Diabetes
Patients with type 2 diabetes more likely to experience signs of kidney, nerve, and eye diseases.
Syringe Services Programs Reduces HIV, Hepatitis C Among Injection Drug Users
Study finds syringe services outreach should be more focused on whites, who now make up a large portion of injection drug users.
Trump Discusses ACA Repeal, FDA Reform, During Address to Congress
President Trump delivered his first presidential address to a joint session of Congress on Tuesday.
Bone Fractures, Osteonecrosis Higher Among Viread Users for HIV
Gilead’s antiretroviral medication associated with the increased risk of fracture in patients with HIV.
Patients Prefer Medical Marijuana Over Prescription Drugs
Patients found to be more likely to seek treatment with medical marijuana than opioids.
Cell Therapy May Be a Possibility for Patients with Type 1 Diabetes
Improved blood glucose control was elicited from the transplantation of reprogrammed pancreatic cells.
Automated Insulin Pump Demonstrates Safety, Efficacy in At-Home Use
MiniMed 670G significantly reduced HbA1c levels in adolescents and adults with type 1 diabetes.
FDA Grants Priority Review to Acute Myeloid Leukemia Drug
Enasidenib is a targeted inhibitor of mutated isocitate dehydrogenase.
FDA Approves Xermelo for Carcinoid Diarrhea Syndrome
Carcinoid syndrome affects some patients with carcinoid tumors.
Prescriber Education Needed for Drug-Induced Weight Gain
Physicians must become more concerned with weight gain side effects of drugs for patients with obesity.
Enasidenib Granted Priority Review For Relapsed or Refractory Acute Myeloid Leukemia
Investigational drug treats patients with relapsed or refractory AML with an isocitrate dehydrogenase 2 mutation.
FDA Approves Drug to Treat Cancer-Related Diarrhea
Xermelo plus somatostatin analog therapy approved to treat carcinoid diarrhea syndrome.
Trending News Today: Lawmakers Again Push for Importing Commerical Drugs from Canada
Nab-paclitaxel Found to Block Cancer Cell Proliferation
Combination therapy shows promise treating pancreatic cancer.
Pancreatic Cancer Drug Takes Multi-Faceted Approach
Nab-paclitaxel prevents proliferation, and increases immune system response to cancer cells.